{
  "id": "c4527bded315dcdf",
  "title": "STAT+: Psilocybin data could be good enough for approval",
  "description": "And other biotech news brought to you by The Readout newsletter",
  "content": "And other biotech news brought to you by The Readout newsletter",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/17/biotech-news-compass-psilocybin-data-for-fda/?utm_campaign=rss",
  "published_at": "2026-02-17T14:57:05+00:00",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Psilocybin data could be good enough for approval",
    "description": "And other biotech news brought to you by The Readout newsletter",
    "url": "https://www.statnews.com/2026/02/17/biotech-news-compass-psilocybin-data-for-fda/?utm_campaign=rss",
    "published": "2026-02-17T14:57:05+00:00",
    "source": "STAT"
  }
}